In the same study, chemical inhibition or genetic deletion of MAP kinase-interacting serin/threonine-protein kinase 1⁄2 (Mnk1/2), as well as inhibition of the EGFR pathway, also led to increased endogenous GJA1-20k expression in both primary and cancer cells. The gene discussed is GJA1; the disease is cancer.